Cargando…
Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study
BACKGROUND: Although no report has demonstrated the efficacy of corticosteroid therapy for autoimmune pulmonary alveolar proteinosis (aPAP), we sometimes encounter patients who have received this therapy for various reasons. However, as corticosteroids can suppress alveolar macrophage function, cort...
Autores principales: | Akasaka, Keiichi, Tanaka, Takahiro, Kitamura, Nobutaka, Ohkouchi, Shinya, Tazawa, Ryushi, Takada, Toshinori, Ichiwata, Toshio, Yamaguchi, Etsuro, Hirose, Masaki, Arai, Toru, Nakano, Kentaro, Nei, Takahito, Ishii, Haruyuki, Handa, Tomohiro, Inoue, Yoshikazu, Nakata, Koh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534060/ https://www.ncbi.nlm.nih.gov/pubmed/26264717 http://dx.doi.org/10.1186/s12890-015-0085-0 |
Ejemplares similares
-
Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution
por: Kitamura, Nobutaka, et al.
Publicado: (2019) -
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan
por: Ishii, Haruyuki, et al.
Publicado: (2014) -
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile
por: Ito, Masayuki, et al.
Publicado: (2017) -
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
por: Hirano, Taizou, et al.
Publicado: (2018) -
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
por: Sakaue, Saori, et al.
Publicado: (2021)